Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian F Chapin

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
European Urology Focus|May 12, 2019
Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial DesignChad A Reichard, Janet Kukreja, Justin R Gregg, et al.
Current Treatment Options in Oncology|January 11, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
The use of PET/CT in prostate cancerRoger Li, Gregory C Ravizzini, Michael A Gorin, et al.
Current Treatment Options in Oncology|April 20, 2024
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
European Urology|April 17, 2018
Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life OutcomesChad A Reichard, Justin R Gregg, Mary F Achim, et al.
Prostate Cancer and Prostatic Diseases|September 11, 2019
Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancerJanet Baack Kukreja, Tharakeswara K Bathala, Chad A Reichard, et al.
Advances in Radiation Oncology|August 6, 2024
Impact of Clinical Factors on <sup>18</sup>F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT StudyBenjamin H Lowentritt, Ashesh B Jani, Brian T Helfand, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
Influence of Geography on Prostate Cancer TreatmentChad Tang, Xiudong Lei, Grace L Smith, et al.
European Urology|May 25, 2015
Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future PerspectivesChristopher E Bayne, Stephen B Williams, Matthew R Cooperberg, et al.
The Journal of Urology|June 23, 2023
Diagnostic Performance and Safety of <sup>18</sup>F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). ReplyAshesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
European Urology Focus|May 12, 2019
Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial DesignChad A Reichard, Janet Kukreja, Justin R Gregg, et al.
Current Treatment Options in Oncology|January 11, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
The use of PET/CT in prostate cancerRoger Li, Gregory C Ravizzini, Michael A Gorin, et al.
Current Treatment Options in Oncology|April 20, 2024
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
European Urology|April 17, 2018
Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life OutcomesChad A Reichard, Justin R Gregg, Mary F Achim, et al.
Prostate Cancer and Prostatic Diseases|September 11, 2019
Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancerJanet Baack Kukreja, Tharakeswara K Bathala, Chad A Reichard, et al.
Advances in Radiation Oncology|August 6, 2024
Impact of Clinical Factors on <sup>18</sup>F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT StudyBenjamin H Lowentritt, Ashesh B Jani, Brian T Helfand, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
Influence of Geography on Prostate Cancer TreatmentChad Tang, Xiudong Lei, Grace L Smith, et al.
European Urology|May 25, 2015
Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future PerspectivesChristopher E Bayne, Stephen B Williams, Matthew R Cooperberg, et al.
The Journal of Urology|June 23, 2023
Diagnostic Performance and Safety of <sup>18</sup>F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). ReplyAshesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, et al.
Pageof 12